Carotid intima-media thickness in children with familial hypercholesterolemia

Circulation Research

Volumn 114, Issue 2, 2014, Pages 307-310

  Kusters, Dorothé M ^a   Wiegman, A ^a   Kastelein, John J P ^a   Hutten, Barbara A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Carotid intima media thickness; Hyperlipoproteinemia type ii; Pediatrics

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER; FLUOROBENZENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

ADOLESCENT; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ARTERY; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG SAFETY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIBLING; AGE; BLOOD; CANADA; CAROTID ARTERY DISEASE; CLINICAL TRIAL; ECHOGRAPHY; EUROPE; GENETICS; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PEDIATRICS; PREDICTIVE VALUE; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; UNITED STATES;

CAROTID INTIMA-MEDIA THICKNESS; HYPERLIPOPROTEINEMIA TYPE II; PEDIATRICS;

ADOLESCENT; AGE FACTORS; BIOLOGICAL MARKERS; CANADA; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHILD; CHOLESTEROL, LDL; EUROPE; FEMALE; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; LINEAR MODELS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PYRIMIDINES; RISK FACTORS; SEX FACTORS; SULFONAMIDES; UNITED STATES;

EID: 84893842871     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.114.301430     Document Type: Article

References (7)

1. de Jongh S, Lilien MR, op't Roodt J, Stroes ES, Bakker HD, Kastelein JJ. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol. 2002;40:2117-2121.
2. Wiegman A, de Groot E, Hutten BA, Rodenburg J, Gort J, Bakker HD, Sijbrands EJ, Kastelein JJ. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet. 2004;363:369-370.
3. McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, Hayman LL, Daniels SR. Drug therapy of high-risk lipid abnormalities in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007;115:1948-1967.
4. Daniels SR, Greer FR; Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122:198-208.
5. Cheng KS, Mikhailidis DP, Hamilton G, Seifalian AM. A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors. Cardiovasc Res. 2002;54:528-538.
6. Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Büller HR, Sijbrands EJ, Kastelein JJ. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: A randomized controlled trial. JAMA. 2004;292:331-337.
7. Rodenburg J, Vissers MN, Wiegman A, van Trotsenburg AS, van der Graaf A, de Groot E, Wijburg FA, Kastelein JJ, Hutten BA. Statin treatment in children with familial hypercholesterolemia: The younger, the better. Circulation. 2007;116:664-668.